{
  "source": "PubMed",
  "query": "catechins",
  "title": "Preclinical evidence construction for epigallocatechin-3-gallate against non-alcoholic fatty liver disease: a meta-analysis and machine learning study.",
  "abstract": "Non-alcoholic fatty liver disease (NAFLD) has emerged as a significant health concern worldwide, exhibiting an increasing incidence that necessitates immediate intervention. Epigallocatechin-3-gallate (EGCG) has shown significant pharmacological benefits for liver diseases, including NAFLD. However, its efficacy in this context has not been systematically evaluated.",
  "publication_date": "2025-04-10",
  "journal": "Phytomedicine : international journal of phytotherapy and phytopharmacology",
  "doi": "10.1016/j.phymed.2025.156651"
}